BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen M, Ye C, Zhu J, Zhang P, Jiang Y, Lu X, Wu H. Bergenin as a Novel Urate-Lowering Therapeutic Strategy for Hyperuricemia. Front Cell Dev Biol 2020;8:703. [PMID: 32850823 DOI: 10.3389/fcell.2020.00703] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Vijeesh V, Vysakh A, Jisha N, Latha M. Multispectroscopic binding studies and in silico docking analysis of interactions of malic acid with xanthine oxidase. Journal of Molecular Structure 2022;1268:133621. [DOI: 10.1016/j.molstruc.2022.133621] [Reference Citation Analysis]
2 Chen M, Ji H, Song W, Zhang D, Su W, Liu S. Anserine beneficial effects in hyperuricemic rats by inhibiting XOD, regulating uric acid transporter and repairing hepatorenal injury. Food Funct 2022. [PMID: 35972268 DOI: 10.1039/d2fo01533a] [Reference Citation Analysis]
3 Zhao ZA, Jiang Y, Chen YY, Wu T, Lan QS, Li YM, Li L, Yang Y, Lin CT, Cao Y, Zhou PZ, Guo JY, Tian YX, Pang JX. CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia. Acta Pharmacol Sin 2022;43:121-32. [PMID: 33767379 DOI: 10.1038/s41401-021-00640-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Sun ZR, Liu HR, Hu D, Fan MS, Wang MY, An MF, Zhao YL, Xiang ZM, Sheng J. Ellagic Acid Exerts Beneficial Effects on Hyperuricemia by Inhibiting Xanthine Oxidase and NLRP3 Inflammasome Activation. J Agric Food Chem 2021;69:12741-52. [PMID: 34672194 DOI: 10.1021/acs.jafc.1c05239] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Zhang G, Wang H, Zhang Q, Zhao Z, Zhu W, Zuo X. Bergenin alleviates H2 O2 -induced oxidative stress and apoptosis in nucleus pulposus cells: Involvement of the PPAR-γ/NF-κB pathway. Environ Toxicol 2021;36:2541-50. [PMID: 34499403 DOI: 10.1002/tox.23368] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Luo X, Yin J, Miao S, Feng W, Ning T, Xu S, Huang S, Zhang S, Liao Y, Hao C, Wu B, Ma D. mTORC1 promotes mineralization via p53 pathway. FASEB J 2021;35:e21325. [PMID: 33508145 DOI: 10.1096/fj.202002016R] [Reference Citation Analysis]
7 Eckenstaler R, Benndorf RA. The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout-An Update. Int J Mol Sci 2021;22:6678. [PMID: 34206432 DOI: 10.3390/ijms22136678] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
8 Chen L, Luo Z, Wang M, Cheng J, Li F, Lu H, He Q, You Y, Zhou X, Kwan HY, Zhao X, Zhou L. The Efficacy and Mechanism of Chinese Herbal Medicines in Lowering Serum Uric Acid Levels: A Systematic Review. Front Pharmacol 2020;11:578318. [PMID: 33568990 DOI: 10.3389/fphar.2020.578318] [Cited by in F6Publishing: 4] [Reference Citation Analysis]